Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Microsoft, Apollo...

    Microsoft, Apollo Hospitals unveil AI to predict cardiovascular disease risk score

    Written by Ruby Khatun Khatun Published On 2018-08-19T10:15:38+05:30  |  Updated On 19 Aug 2018 10:15 AM IST
    Microsoft, Apollo Hospitals unveil AI to predict cardiovascular disease risk score

    New Delhi: Microsoft India and Apollo Hospitals have partnered to build an artificial intelligence-powered platform, designed to predict the risk of Cardiovascular Disease (CVD) in the Indian population.


    Under the collaboration, which is part of Microsoft's AI Network for Healthcare initiative, the two entities have launched an AI-powered Cardiovascular Disease Risk Score API (application program interface) that can be used by doctors across the Apollo network of hospitals to predict risk of CVD and drive preventive cardiac care across the country, a statement today said.


    Apollo and Microsoft are also engaging global consortium partners to calibrate and scale this intelligent system for other population groups, the statement said.

    According to the National Family Health survey by the Health Ministry, one in eight Indians suffers from high blood pressure. The statement noted that while there are various CVD risk models available worldwide, these do not cater specifically to the Indian population.

    Built on Microsoft Azure, the said API aims to determine a more accurate CVD risk score for the Indian population, the statement added.

    The API has been developed using a combination of applied AI and clinical expertise on a large sample of retrospective data on health checks and coronary events. The scoring considers risk contributors including lifestyle attributes like diet, tobacco and smoking preferences, physical activity as well as psychological stress and anxiety as reflected via rate of respiration, hypertension and systolic and diastolic blood pressure.

    The score categorizes risk into high, moderate and minimal and using the insights, physicians can make timely intervention and help patients with the lifestyle modifications needed.

    "This partnership is part of our continuing endeavour to design new tools and equip our doctors in the fight against non-communicable diseases. The amalgamation of AI and machine learning with the global expertise of our doctors will help prevent heart disease, save lives and ensure those with heart disease can make informed choices on their health," Apollo Hospitals Joint Managing Director Sangita Reddy said.

    This heart risk score for Indian populace is an example of how precision healthcare can accelerate prevention of cardiovascular disease and reduce disease burden, said Microsoft India (R&D) Managing Director Anil Bhansali said.
    AIAnil BhansaliAPIApollo Hospitalsartificial intelligenceCardiovascular diseaseCollaborationCVDHealth MinistryMicrosoftMicrosoft AzureNational Family Health surveyNon Communicable DiseasesriskSangita Reddyscore
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok